Timothy Rebbeck, Vincent L. Gregory, Jr. Professor of Cancer Prevention at Harvard T.H. Chan School of Public Health, and Professor at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“It’s time to take a hard look at how we approach cancer early detection with liquid biopsy tools.
- Do we need better test performance?
- Smarter targeting of populations?
- Clearer definitions of what ‘success’ truly looks like?
There’s still a long way to go-but the need for effective early detection has never been greater.
Read also:
- Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate
- Grail’s Cancer Detection Test Fails in Major Study.”
Other articles featuring Timothy Rebbeck on OncoDaily.